Navigation Links
Stipkala LLC to Sponsor Texas Life Science Conference November 12-13, 2009
Date:11/9/2009

HOUSTON, Nov. 9 /PRNewswire/ -- Patent attorneys Cheryl Liljestrand, Ph.D, J.D., and Jeremy M. Stipkala, Ph.D., J. D., will showcase Stipkala LLC at the Texas Life Science Conference November 12-13, 2009, which will be held at the Institute of Molecular Medicine in Houston, TX. The Texas Life Science Conference provides a platform for cutting-edge companies to introduce their growth opportunities to investors, and will feature keynote addresses and panel discussions on industry perspectives, viable business models, cash management, alternative financing, and other useful topics. Also, receptions and dine-arounds will offer ample networking opportunities for national and local venture capitalists, biotechnology entrepreneurs, and service providers.

The Texas Life Science Conference will highlight some of the state's leading biotechnology enterprises. Companies that headquarter in Texas or have a primary technology licensed from a Texas research university are encouraged to attend. For more information about the conference, or to register online, please visit: http://www.texaslifescienceconference.com/index.html.

Dr. Liljestrand specializes in patenting biotechnology, immunology, pharmaceutical, and biologic innovations from her office in Pearland, TX. Dr. Stipkala focuses on chemical and pharmaceutical inventions, among others. Stipkala LLC, a premier nationwide intellectual property law firm, proudly supports the Conference as a Gold Sponsor, and will give each attendee a special gift. For more information about Stipkala LLC, please visit: www.StipkalaLaw.com.

SOURCE Stipkala LLC


'/>"/>
SOURCE Stipkala LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
2. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
3. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
4. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
5. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
6. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
7. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
10. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
11. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
Breaking Medicine Technology:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle ... 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of the facility. ... area-residents to celebrate two great years while also familiarizing themselves with the facility. ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... Harris Communications, ... of hearing, is bringing its latest products to the Deaf Seniors of America Conference, ... have the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and ...
(Date:3/25/2017)... ... ... at Swissray is pleased to announce the release of the ELITE DXA, a new ... active scan window, which is more than double that of existing bone densitometers. Historically, ... undergo an accurate total body bone density or body composition study. The ELITE ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
Breaking Medicine News(10 mins):